LEONI, Pietro
 Distribuzione geografica
Continente #
NA - Nord America 12.491
EU - Europa 7.753
AS - Asia 6.303
SA - Sud America 1.697
AF - Africa 416
Continente sconosciuto - Info sul continente non disponibili 27
OC - Oceania 10
Totale 28.697
Nazione #
US - Stati Uniti d'America 12.297
SG - Singapore 1.907
UA - Ucraina 1.410
VN - Vietnam 1.350
BR - Brasile 1.347
RU - Federazione Russa 1.290
CN - Cina 903
SE - Svezia 860
IT - Italia 809
DE - Germania 768
IE - Irlanda 711
TR - Turchia 677
DK - Danimarca 542
HK - Hong Kong 514
FR - Francia 448
FI - Finlandia 409
KR - Corea 295
GB - Regno Unito 278
CI - Costa d'Avorio 155
IN - India 146
MA - Marocco 127
AR - Argentina 107
BD - Bangladesh 100
CA - Canada 82
MX - Messico 78
IQ - Iraq 61
ZA - Sudafrica 60
EC - Ecuador 58
CO - Colombia 57
ID - Indonesia 54
JP - Giappone 44
PL - Polonia 44
VE - Venezuela 42
UZ - Uzbekistan 36
PK - Pakistan 35
NL - Olanda 33
PH - Filippine 30
BE - Belgio 29
PY - Paraguay 29
ES - Italia 27
EU - Europa 25
AT - Austria 24
CL - Cile 22
JO - Giordania 22
DZ - Algeria 18
MY - Malesia 18
PE - Perù 16
TN - Tunisia 15
CZ - Repubblica Ceca 12
KZ - Kazakistan 11
NP - Nepal 11
RO - Romania 11
AE - Emirati Arabi Uniti 10
ET - Etiopia 10
KE - Kenya 10
UY - Uruguay 10
AZ - Azerbaigian 9
LT - Lituania 9
OM - Oman 9
AU - Australia 8
BG - Bulgaria 8
BO - Bolivia 8
SA - Arabia Saudita 8
LB - Libano 7
EG - Egitto 6
TH - Thailandia 6
TW - Taiwan 6
IL - Israele 5
IR - Iran 5
JM - Giamaica 5
AL - Albania 4
CG - Congo 4
CH - Svizzera 4
CR - Costa Rica 4
EE - Estonia 4
GR - Grecia 4
GT - Guatemala 4
PR - Porto Rico 4
BA - Bosnia-Erzegovina 3
BZ - Belize 3
DO - Repubblica Dominicana 3
HN - Honduras 3
HR - Croazia 3
KG - Kirghizistan 3
KW - Kuwait 3
SN - Senegal 3
BB - Barbados 2
BH - Bahrain 2
GE - Georgia 2
HU - Ungheria 2
MD - Moldavia 2
MM - Myanmar 2
MN - Mongolia 2
NI - Nicaragua 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
Totale 28.675
Città #
Jacksonville 1.424
Ashburn 1.409
Singapore 1.088
Chandler 1.049
Fairfield 779
Dublin 707
Boardman 704
Dallas 697
Hong Kong 494
Wilmington 474
Ho Chi Minh City 438
New York 364
Woodbridge 351
San Jose 341
Houston 308
Seattle 293
San Mateo 291
Lawrence 286
Princeton 286
Hanoi 285
Lauterbourg 252
The Dalles 245
Des Moines 233
Moscow 221
Cambridge 212
Beijing 205
Los Angeles 193
Ann Arbor 189
Hefei 171
Centro 166
Abidjan 155
San Diego 116
São Paulo 112
Buffalo 93
Munich 93
Redmond 93
Helsinki 89
Da Nang 83
Porto 79
Orem 72
Haiphong 54
Turin 53
London 45
Shanghai 45
Milan 44
Tokyo 36
Guangzhou 34
Pune 34
Rio de Janeiro 34
Turku 34
Curitiba 33
Warsaw 33
Chicago 32
Santa Clara 32
Chennai 31
Stockholm 30
Tashkent 29
Brooklyn 28
Hải Dương 28
Phoenix 28
Norwalk 27
Pianella 27
Brussels 26
Johannesburg 25
Montreal 25
Biên Hòa 24
Belo Horizonte 23
Marche 23
Porto Alegre 23
Denver 22
Manchester 22
Mexico City 22
Amman 21
Baghdad 21
Nuremberg 21
Poplar 21
Frankfurt am Main 20
Izmir 20
Toronto 20
Atlanta 19
Rome 19
Amsterdam 18
Boston 18
Guayaquil 18
Medellín 18
San Francisco 17
Thái Nguyên 17
Ancona 16
Auburn Hills 16
Brasília 16
Civitanova Marche 15
Council Bluffs 15
Elk Grove Village 15
Washington 15
Wuhan 15
Campinas 14
Dhaka 14
Guarulhos 14
Quito 14
Vienna 14
Totale 16.627
Nome #
Human white adipocytes convert into “rainbow” adipocytes in vitro 259
Human de-differentiated adipocytes show similar properties to bone marrow derived mesenchymal stem cells 214
Feasibility and Outcome of a Phase II Study of Intensive Induction Chemotherapy in 91 Elderly Patients with AML Evaluated Using a Simplified Multidimensional Geriatric Assessment 208
Differences in survivin localization and Bcl-2 expression in CD30+ lymphoproliferative disorderd of the skin compared to systemic anaplastic large cell lymphomas: an immunohistochemical study 193
Low-dose Gemtuzumab-Ozogamicin as post-consolidation therapy in elderly patients with acute myeloid leukaemia: a pilot study. 186
Diagnostic delay and prognosis in primary central nervous system lymphoma compared with glioblastoma multiforme 175
Conditioning regimen with beam plus amifostine for outpatient autologous stem cell tansplantation: feasibility and outcome in 97 lymphoma patients. 173
A predictive model of varicella-Zoster virus infection after autologous peripheral blood progenitor cell transplantation 170
Abnormalities of erythropoiesis during HIV-1 disease: a longitudinal analysis. 170
Glial-like differentiation potential of human mature adipocytes 166
A new method to assess the viability of collected CD34+ cells before reinfusion: a prospective study in 50 autotransplanted patients. 165
A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol 159
Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced conditioning. 158
Mobilization-Driven Postconsolidation Therapy in Elderly Patients with Acute Myeloid Leukemia: Feasibility and Efficacy of Autologous Stem Cell Transplantation versus Low-Dose Gemtuzumab Ozogamicin 156
Primary B-cell lymphoblastic lymphoma of the testis 156
Efficacy and feasibility of high-dose cytarabine plus idarubicin and amifostine as induction schedule: a prospective observational study of 100 AML elderly patients 154
A Combination of Lenalidomide and Rituximab (ReRi) As Salvage Therapy in Elderly Patients Affected By Diffuse Large B Cells (DLBCL) Lymphoma Relapsed and Refractory 154
Human bone marrow adipocytes maintain the survival and differentiation of hematopoietic stem cells 152
[Hodgkin's lymphoma and secondary leukemias]. 152
[Differentiating agents in myelodysplastic syndromes. Analysis of personal cases]. 150
Azacitidine Treatment in High Risk Myelodysplastic Patients in Complete Haematological Remission Reverts Mesenchymal Stem Cells to a Normal Phenotype 150
[Autoimmune thrombocytopenic purpura and circulating immune complexes]. 148
Thrombosis in essential thrombocytemia and early/prefibrotic primary myelofibrosis: The role of the WHO histological diagnosis 148
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 147
A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell transplantation. 147
Thalidomide, dexamethasone, and pegylated liposomal doxorubicin (ThaDD) for patients older than 65 years with newly diagnosed multiple myeloma. 147
Meningioma-like cerebral relapse of Hodgkin's disease. 145
Comparison of germinal center markers CD10, BCL6 and human germinal center-associated lymphoma (HGAL) in follicular lymphomas 143
Aging- and Senescence-associated Changes of Mesenchymal Stromal Cells in Myelodysplastic Syndromes 142
Common and rare side-effects of low-dose thalidomide in multiple myeloma: focus on the dose-minimizing peripheral neuropathy 141
Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cell autotransplant: a retrospective study 141
Ematuria ed emospermia ricorrenti: uniche manifestazioni di malattia di von Willebrand di tipo I. First report 141
Biosafety evidence for human dedifferentiated adipocytes 141
Direct demonstration of cytokeratin filaments by electron microscopy in K562 cell lines in liquid culture 140
[Polyneuropathies associated with lymphoplasmacytic dyscrasias: the clinical and instrumental characteristics of a 38-patient case load]. 139
Reversal of poor graft function with iron-chelating therapy after allogeneic transplantation for severe aplastic anemia 139
Coexistence of two discordant B-cell lymphomas in the skin and lymph node: report of a case with primary cutaneous follicle-center lymphoma and nodal mantle-cell lymphoma. 138
[Evaluation of the colonization efficiency and in vitro drug sensitivity of the continuous K 562 line]. 138
Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromes. 138
Cytokine expression profile of selected cell populations from patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation wih reduced conditioning. 137
Spontaneous recurrent hematuria and hematospermia: Unique manifestations of von Willebrand disease type I. Case report 137
Gemtuzumab-Ozogamicin as Post-Consolidation Therapy In Elderly Patients with Acute Myeloid Leukemia: a Pilot Study 137
A new intensive induction schedule, including high-dose Idarubicin, high-dose Aracytin and Amifostine, in older AML patients: feasibility and long-term results in 42 patients. 136
Plasticity of human dedifferentiated adipocytes toward endothelial cells 136
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma 136
Primary testicular lymphoblastic B lymphoma: ultrasonographic features and clinical implications 136
Human AB serum for generation of mesenchymal stem cells from human chorionic villi: comparison with other source and other media including platelet lysate 135
LATE EFFECTS IN Hodgkin's POPULATION Treated BETWEEN 1980-2005 IN A SINGLE INSTITUTION 135
Density of neoplastic lymphoid infiltrate, CD8+ T cells, and CD1a+ dendritic cells in mycosis fungoides. 134
Hematologic reconstitution after PBPC autotransplantation:comparison between programmed-rate freezing and uncontrolled freezing at –80° 133
Modern management of anthracycline-induced cardiotoxicity in lymphoma patients: Low occurrence of cardiotoxicity with comprehensive assessment and tailored substitution by nonpegylated liposomal doxorubicin 133
Human Mesenchymal Stem Cells from chorionic villi and amniotic fluid are not susceptible to transformation after extensive in vitro expansion 133
Tailored Therapy in an Unselected Population of 91 Elderly Patients with DLBCL Prospectively Evaluated Using a Simplified CGA. 130
Bone marrow adipocytes support haematopoietic stem cell survival 130
A circulating T cell clone in early Mycosis Fungoides is not a negative prognostic factor when the disease is treated by a combination of PUVA plus interferon alpha 129
Preventive Effects of Cardotoxicities By Liposomal Anthracyclines non Pegilated in 95 Perspective Patients Affected By Lymphoma and Monitored By Biomarkers and Ecocardiography 129
[Polychemotherapy versus melphalan-prednisone in multiple myeloma]. 128
Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase 3 study 127
Clinicopathological features of primary cutaneous B-cell lymphomas from an academic regional hospital in central Italy: no evidence of Borrelia burgdorferi association 126
Bendamustine, Bortezomib and Dexamethasone (BVD): A Combination With a Substantial Activity and a Manageable Toxicity In Patients With Relapsed-Refractory Multiple Myeloma (MM) 126
Screening of psychological distress in oncology and hematology department at Ospedali Riuniti Ancona 126
LA POSITIVITÀ DEL WT1 POST-INDUZIONE È UN IMPORTANTE FATTORE PROGNOSTICO PREDITTIVO DI RECIDIVA PRECOCE IN UNA CASISTICA DI 80 PAZIENTI AFFETTI DA LEUCEMIA ACUTA MIELOIDE 125
Severe diarrhoea During Campath-1H Treatment For Refractory Cutaneous T Cell Lymphoma 125
Diffuse large B-cell lymphoma with Homer-Wright rosettes, sinusoidal growth pattern, and CD30 expression: a possible overlapping between micovillous lymphomas and sinusal CD30-positive large B-cell lymphomas. 124
A case of monoclonal gammopathy of undetermined significance (MGUS): type IgD-lambda. 124
A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell trasplantation 123
Hematologic reconstitution after PBPC autotransplantation: comparison between programmed-rate freezing and uncontrolled-rate freezing at -80 degrees C 123
Overexpression of CDKN2B (p15INK4B) and altered global DNA methylation status in mesenchymal stem cells of high-risk myelodysplastic syndromes 123
[Beta 2-microglobulin in lymphoproliferative disorders]. 122
[Hairy cell leukemia: therapy with lithium carbonate]. 122
Molecular and functional characterization of human bone marrow adipocytes 122
[Peripheral neuropathy associated with Castleman's lymphoma]. 121
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study 120
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD 120
Consensus recommendations for improvement of unmet clinical needs-the example of chronic graft-versus-host disease: A systematic review and meta-analysis 120
Bone marrow extracellular large geometric crystals in IgG/λ MGUS 119
Interaction between human mature adipocytes and lymphocytes induces T-cell proliferation 119
Central nervous system involvement is a negative prognostic factor in primary cutaneous B-cell lymphoma. 119
Efficacy and safety of eltrombopag for the treatment of thrombocytopenia of low and intermediate-1 IPSS risk myelodysplastic syndromes: interim analysis of a prospective, randomized, single-blind, placebo-controlled trial (EQoL-MDS) 117
Immunostaining for nucleophosmin in bone marrow trephine biopsy specimens in acute myeloid leukemias 117
Patients with chronic extensive GvHD produce high levels of stimulatory auto-antibodies to the PDGF receptor: a new pathophysiological pathway of the disease progression 117
Efficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II study 117
CD8+ lymphocytes and CD1a+ dendritic cells in mycosis fungoides: correlation with epidermotropism, subepidermal lymphoid infiltrate, response to therapy and disease recurrence 116
Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia 116
Selection of CD271(+) cells and human AB serum allows a large expansion of mesenchymal stromal cells from human bone marrow 115
DHAP regimen plus G-CSF as salvage therapy and priming for blood progenitor cell collection in patients with poor prognosis lymphoma. 115
Identification of different adypocytes populations within human marrow microenvironment 115
Unusual Site Thrombosis: Focus on Myeloproliferative Neoplasms with Splachnic or Cerebral Venous Thrombosis 115
Prognostic clinical, laboratoristic and molecular factors in mycosis fungoides 114
Paroxysmal atrial fibrillation after high-dose melphalan in five patients autotransplanted with blood progenitor cells. 114
Combined administration of alpha-erythropoietin and filgrastim can improve the outcome and cost balance of autologous stem cell transplantation in patients with lymphoproliferative disorders. 113
Stimulatory autoantibodies against PDGF receptor in serum from patients with GVHD and scleroderma-like changes 113
Prospective multicentric Clinical trial on the use of Interferon-a plus PUVA in patients with early stage Mycosis Fungoides. 112
Early stage Mycosis Fungoides treated with IFNalpha2b and PUVA: molecular analysis of T cell monoclonality by PCR in skin biopsies during and after therapy. 112
Bone Marrow histopathological and molecular changes of small B-cell lymphomas after rituximab therapy: comparison with clinical response and patients autcome 112
PBSC mobilization, collection and positive selection in patients with chronic lymphocytic leukemia. 112
Thalidomide plus oral melphalan for advanced multiple myeloma: a phase Ii study 111
Gemcitabine alone or combined with cisplatin in relapsed or refractory multiple mieloma 111
The role of BCR/ABL isoforms in the presentation and outcome of patients with Philadelphia-positive acute lymphoblastic leukemia: a seven-year update of the GIMEMA 0496 trial 111
The risk of non-Hodgkin's lymphoma in coeliac disease: a case-control, multicentre study 110
Totale 13.668
Categoria #
all - tutte 130.769
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 130.769


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021800 0 0 0 0 0 0 0 0 0 266 388 146
2021/20222.187 99 620 23 176 16 79 99 171 115 178 158 453
2022/20233.296 343 373 278 258 254 492 1 172 864 19 178 64
2023/20241.955 350 49 102 341 334 369 27 46 5 38 20 274
2024/20253.923 429 424 172 48 169 78 486 113 868 285 353 498
2025/20269.277 707 793 707 1.237 898 726 1.713 1.040 785 671 0 0
Totale 29.058